Myocardial Injury in Patients with Hip Fracture
Journal of Bone and Joint Surgery · 18.12.2024 · 106 (24) · 2303-2312
DOI: 10.2106/jbjs.23.01459 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 25.07.2024. Verfasst von Flavia K Borges und 35 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Hip Fractures, Troponin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Myocardial injury after a hip fracture is common and has a poor prognosis. Patients with a hip fracture and myocardial injury may benefit from accelerated surgery to remove the physiological stress associated with the hip fracture. This study aimed to determine if accelerated surgery is superior to standard care in terms of the 90-day risk of death in patients with a hip fracture who presented with an elevated cardiac biomarker/enzyme measurement at hospital arrival.
Methods
The HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) trial was a randomized controlled trial designed to determine whether accelerated surgery for hip fracture was superior to standard care in reducing death or major complications. This substudy is a post-hoc analysis of 1392 patients (from the original study of 2970 patients) who had a cardiac biomarker/enzyme measurement (>99.9% had a troponin measurement and thus “troponin” is the term used throughout the paper) at hospital arrival. The primary outcome was all-cause mortality. The secondary composite outcome included all-cause mortality and non-fatal myocardial infarction, stroke, and congestive heart failure 90 days after randomization.
Results
Three hundred and twenty-two (23%) of the 1392 patients had troponin elevation at hospital arrival. Among the patients with troponin elevation, the median time from hip fracture diagnosis to surgery was 6 hours (interquartile range [IQR] = 5 to 13) in the accelerated surgery group and 29 hours (IQR = 19 to 52) in the standard care group. Patients with troponin elevation had a lower risk of mortality with accelerated surgery compared with standard care (17 [10%] of 163 versus 36 [23%] of 159; hazard ratio [HR] = 0.43 [95% confidence interval (CI) = 0.24 to 0.77]) and a lower risk of the secondary composite outcome (23 [14%] of 163 versus 47 [30%] of 159; HR = 0.43 [95% CI = 0.26 to 0.72]).
Conclusions
One in 5 patients with a hip fracture presented with myocardial injury. Accelerated surgery resulted in a lower mortality risk than standard care for these patients; however, these findings need to be confirmed. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health Research Institute, Hamilton, Ontario, Canada.
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
- Department of Orthopaedic Surgery and Traumatology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
- Departament de Cirugia, Universitat Autonoma de Barcelona, Barcelona, Spain.
- Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Flavia K Borges, Ernesto Guerra-Farfan, Mohit Bhandari, Ameen Patel, Gerard Slobogean, Robert J Feibel, Parag K Sancheti, Maria E Tiboni, Mariano Balaguer-Castro, Vikas Tandon, Jordi Tomas-Hernandez, Alben Sigamani, Alen Sigamani, Wojciech Szczeklik, Stephen J McMahon, Masood Umer, Richard J Jenkinson, Abdel Lawendy, Ekaterine Popova, Chew Yin Wang, Bruce M Biccard, Sandra Ofori, Jessica Spence, Emmanuelle Duceppe, Maura Marcucci, Valerie Harvey, Kumar Balasubramanian, Jessica Vincent, Ana Claudia Tonelli
Zitieren
APA
Borges, F. K., Guerra-Farfan, E., Bhandari, M., Patel, A., Slobogean, G., Feibel, R. J., Sancheti, P. K., Tiboni, M. E., Balaguer-Castro, M., Tandon, V., Tomas-Hernandez, J., Sigamani, A., Sigamani, A., Szczeklik, W., McMahon, S. J., Ślęczka, P., Ramokgopa, M. T., Adinaryanan, S., Umer, M., …, & HIP ATTACK Investigators (2024). Myocardial Injury in Patients with Hip Fracture. Journal of Bone and Joint Surgery, 106(24), 2303-2312. https://doi.org/10.2106/jbjs.23.01459
Vancouver
Borges FK, Guerra-Farfan E, Bhandari M, Patel A, Slobogean G, Feibel RJ, et al. Myocardial Injury in Patients with Hip Fracture. Journal of Bone and Joint Surgery. 2024;106(24):2303-2312. doi:10.2106/jbjs.23.01459
BibTeX
@article{Borges2024,
author = {Borges, Flavia K and Guerra-Farfan, Ernesto and Bhandari, Mohit and Patel, Ameen and Slobogean, Gerard and Feibel, Robert J and Sancheti, Parag K and Tiboni, Maria E and Balaguer-Castro, Mariano and Tandon, Vikas and Tomas-Hernandez, Jordi and Sigamani, Alben and Sigamani, Alen and Szczeklik, Wojciech and McMahon, Stephen J and Ślęczka, Pawel and Ramokgopa, Mmampapatla T and Adinaryanan, S and Umer, Masood and Jenkinson, Richard J and Lawendy, Abdel and Popova, Ekaterine and Nur, Aamer Nabi and Wang, Chew Yin and Vizcaychipi, Marcela and Biccard, Bruce M and Ofori, Sandra and Spence, Jessica and Duceppe, Emmanuelle and Marcucci, Maura and Harvey, Valerie and Balasubramanian, Kumar and Vincent, Jessica and Tonelli, Ana Claudia and Devereaux, P J and HIP ATTACK Investigators, HIP ATTACK Investigators},
title = {Myocardial Injury in Patients with Hip Fracture},
journal = {Journal of Bone and Joint Surgery},
year = {2024},
volume = {106},
number = {24},
pages = {2303--2312},
doi = {10.2106/jbjs.23.01459}
}
EUVIMED